The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism

Journal of Cell Science

Volumn 118, Issue 4, 2005, Pages 771-780

  Scharpfenecker, Marion ^a   Fiedler, Ulrike ^a   Reiss, Yvonne ^a   Augustin, Hellmut G ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Angiogenesis; Angiopoietin; Endothelial cells

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; LIGAND; RETROVIRUS VECTOR; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; CELL ADHESION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPHEROID CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM;

ANGIOPOIETIN-2; AUTOCRINE COMMUNICATION; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; LIGANDS; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, TIE-2;

UNIDENTIFIED RETROVIRUS;

EID: 14944377120     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01653     Document Type: Article

References (47)

1. Augustin, H. G. and Reiss, Y. (2003). EphB receptors and ephrinB ligands: regulators of vascular assembly and homeostasis. Cell Tissue Res. 314, 25-31.
2. Brown, C., Gaspar, J., Pettit, A., Lee, R., Gu, X., Wang, H., Manning, C., Voland, C., Goldring, S. R., Goldring, M. B. et al. (2004). ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J. Biol. Chem. 279 12794-12803.
3. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
4. Cho, C. H., Kammerer, R. A., Lee, H. J., Yasunaga, K., Kim, K. T., Choi, H. H., Kim, W., Kim, S. H., Park, S. K., Lee, G. M. et al. (2004). Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad Sci. USA 101, 5553-5558.
5. Das, A., Fanslow, W., Cerretti, D., Warren, E., Talarico, N. and McGuire, P. (2003). Angiopoietin/Tek interactions regulate MMP-9 expression and retinal neovascularization. Lab. Invest. 83 1637-1645.
6. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C. et al. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
7. Davis, S., Papadopoulos, N., Aldrich, T. H., Maisonpierre, P. C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A. et al. (2003). Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10, 38-44.
8. Fiedler, U., Krissl, T., Koidl, S., Weiss, C., Koblizek, T., Deutsch, U., Martiny-Baron, G., Marme, D. and Augustin, H. G. (2003). Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J. Biol. Chem. 278, 1721-1727.
9. Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G. and Augustin, H. G. (2004). The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103, 4150-4156.
10. Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D. et al. (2002). Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3, 411-423.
11. Gamble, J. R., Drew, J., Trezise, L., Underwood, A., Parsons, M., Kasminkas, L., Rudge, J., Yancopoulos, G. and Vadas, M. A. (2000). Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87, 603-607.
12. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V. and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J. Biol. Chem. 273, 30336-30343.
13. Gerber, H. P., Malik, A. K., Solar, G. P., Sherman, D., Liang, X. H., Meng, G., Hong, K., Marsters, J. C. and Ferrara, N. (2002). VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417, 954-958.
14. Goede, V., Schmidt, T., Kimmina, S., Kozian, D. and Augustin, H. G. (1998). Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78, 1385-1394.
15. Gortz, A., Nibbs, R. J., McLean, P., Jarmin, D., Lambie, W., Baird, J. W. and Graham, G. J. (2002). The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function. J. Immunol. 169, 1387-1394.
16. Hackett, S. F., Ozaki, H., Strauss, R. W., Wahlin, K., Suri, C., Maisonpierre, P., Yancopoulos, G. and Campochiaro, P. A. (2000). Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J. Cell Physiol. 184, 275-284.
17. Hammes, H. P., Lin, J., Wagner, P., Feng, Y., Vom Hagen, F., Krzizok, T., Renner, O., Breier, G., Brownlee, M. and Deutsch, U. (2004). Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53 1104-1110.
18. Hanahan, D. (1997). Signaling vascular morphogenesis and maintenance. Science 277, 48-50.
19. Hegen, A., Koidl, S., Weindel, K., Marme, D., Augustin, H. G. and Fiedler, U. (2004). Expression of Angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler. Thromb. Vasc. Biol. 24, 1803-1809.
20. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D. and Wiegand, S. J. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998.
21. Huang, Y. Q., Li, J. J., Hu, L., Lee, M. and Karpatkin, S. (2002). Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 99, 1646-1650.
22. Jeon, B. H., Khanday, F., Deshpande, S., Haile, A., Ozaki, M. and Irani, K. (2003). Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB. Circ. Res. 92, 586-588.
23. Jones, N., Iljin, K., Dumont, D. J. and Alitalo, K. (2001). Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2, 257-267.
24. Keating, M. T. and Williams, L. T. (1988). Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239, 914-916.
25. Kim, I., Kim, J. H., Moon, S. O., Kwak, H. J., Kim, N. G. and Koh, G. Y. (2000). Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19, 4549-4552,
26. Korff, T. and Augustin, H. G. (1999). Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J. Cell Sci. 112, 3249-3258.
27. Korff, T., Kimmina, S., Martiny-Baron, G. and Augustin, H. G. (2001). Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 15, 447-457.
28. Lobov, I. B., Brooks, P. C. and Lang, R. A. (2002). Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. USA 99, 11205-11210.
29. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N. et al. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
30. Mandriota, S. J. and Pepper, M. S. (1998). Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83, 852-859.
31. Mochizuki, Y., Nakamura, T., Kanetake, H. and Kanda, S. (2002). Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J. Cell Sci. 115, 175-183.
32. Niu, Q., Perruzzi, C., Voskas, D., Lawler, J., Dumont, D. J. and Benjamin, L. E. (2004). Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1. Cancer Biol. Ther. 3, 402-405.
33. Nykanen, A. I., Krebs, R., Saaristo, A., Turunen, P., Alitalo, K., Yla-Herttuala, S., Koskinen, P. K. and Lemstrom, K. B. (2003). Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107, 1308-1314.
34. Ramsauer, M. and D'Amore, P. A. (2002). Getting Tie(2)d up in angiogenesis. J. Clin. Invest. 110, 1615-1617.
35. Re, R. N. (2003). The intracrine hypothesis and intracellular peptide hormone action. BioEssays 25, 401-409.
36. Stratmann, A., Risau, W. and Plate, K. H. (1998). Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153, 1459-1466.
37. Sugimachi, K., Tanaka, S., Taguchi, K., Aishima, S., Shimada, M. and Tsuneyoshi, M. (2003). Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J. Clin. Pathol. 56, 854-860.
38. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
39. Teichert-Kuliszewska, K., Maisonpierre, P. C., Jones, N., Campbell, A. I., Master, Z., Bendeck, M. P., Alitalo, K., Dumont, D. J., Yancopoulos, G. D. and Stewart, D. J. (2001). Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49, 659-670.
40. Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M. and Yancopoulos, G. D. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463.
41. Vikkula, M., Boon, L. M., Carraway, K. L., III, Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C. et al. (1996). Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181-1190.
42. Visconti, R. P., Richardson, C. D. and Sato, T. N. (2002). Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endotheliai growth factor (VEGF). Proc. Natl. Acad. Sci. USA 99, 8219-8224.
43. Werman, A., Werman-Venkert, R., White, R., Lee, J. K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A. and Apte, R. N. (2004). The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 101, 2434-2439.
44. Wong, A. L., Haroon, Z. A., Werner, S., Dewhirst, M. W., Greenberg, C. S. and Peters, K. G. (1997). Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 81, 567-574.
45. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
46. Yoon, M. J., Cho, C. H., Lee, C. S., Jang, I. H., Ryu, S. H. and Koh, G. Y. (2003). Localization of Tie2 and phospholipase D in endothelial caveolae is involved in angiopoietin-1-induced MEK/ERK phosphorylation and migration in endothelial cells. Biochem. Biophys. Res. Commun. 308, 101-105.
47. Zhang, L., Yang, N., Park, J. W., Katsaros, D., Fracchioli, S., Cao, G., O'Brien-Jenkins, A., Randall, T. C., Rubin, S. C. and Coukos, G. (2003). Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 63, 3403-3412.